Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial

BACKGROUND: The main purpose of this study is to compare the vitreous hemorrhage (VH) score reduction and visual acuity outcomes in patients with VH secondary to proliferative diabetic retinopathy (PDR) treated with intravitreal injections of bevacizumab (IVB) versus IVB and pars plana vitrectomy (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorge, Danilo Moyses, Tavares Neto, José Edísio da Silva, Poli-Neto, Omero Benedicto, Scott, Ingrid U., Jorge, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074210/
https://www.ncbi.nlm.nih.gov/pubmed/33902755
http://dx.doi.org/10.1186/s40942-021-00296-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074210/
https://www.ncbi.nlm.nih.gov/pubmed/33902755
http://dx.doi.org/10.1186/s40942-021-00296-7

Ejemplares similares